Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company
The U.S. Federal Trade Commission (FTC) has approved Aurobindo Pharma's proposed acquisition of Pennsylvania-based generic pharmaceutical firm Lannett Company. Valued at $250 million on a cash-free, debt-free basis and inclusive of normalised…
Sun Pharma, Aurobindo Pharma, Tata Motors, Aavas Financiers, Patanjali, Power Mech, RVNL and 20 more stocks will remain in focus on Monday , June 22
Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in an all-cash deal valued for ₹271 crore ($28.73 million). Sun Pharma said it has signed an agreement to acquire 100 per cent of the outstanding…
Aurobindo Pharma gets US FTC's nod to acquire Lannett Company
Aurobindo Pharma 's wholly owned arm in the US has received approval from the US Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC. The transaction, valued at $250 million on a cash-free, debt-free basis and…
Pharma Momentum Fuels Johnson & Johnson's Path to Double-Digit Upside
Our Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) 24/7 Wall St. price target lands at $261.72, pointing to 11.28% upside from the current price of $235.18. Our recommendation is buy, and our model carries a 90% confidence level. JNJ has…
5 More AI Predictions For The Year 2030
Prediction #2: TSMC's and ASML's monopolies will be broken. The semiconductor supply chain will be dramatically transformed. Two years ago, we published a list of 5 predictions about AI in the year 2030. The article sparked a lot of fascinating…
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1…
The annoying truth behind the illusion of the low dollar
The insane food prices in Israel have received a variety of colorful descriptions over the years, but it seems that the metaphor heard yesterday during the discussion in the Knesset Economic Affairs Committee, regarding the lack of impact of the…
/afaqs/media/media_files/2026/06/22/daburered-2026-06-22-00-04-38.jpg)
Can Dabur make Lal Dant Manjan cool again? Ravi Kishan fronts the desi revival
Over the decades, the Indian bathroom shelf has shifted from the familiar red tooth powders, once trusted by grandparents—to toothpastes from multinational brands—minty white or even a splash of purple (if you know, you know)…
This Geothermal Startup Plans To Use Oil Tech For Green Energy
A new geothermal player. Upgrading the grid with wood veneers. How drones are leveling the military playing field. All that and more in this week's Prototype. To get it in your inbox, sign up here. Geothermal energy is hot right now. Energy demand…
The 2 Factors That Will Decide Whether XLV Finally Catches the S&P 500 in 2026
The Health Care Select Sector SPDR ETF (NYSEARCA:XLV) is having a frustrating year. The fund sits at $149, down about 3% year-to-date while the broader market grinds higher. The good news for XLV holders: the fund has clawed back roughly 14% over…
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Given Consensus Recommendation of 'Moderate Buy' by Analysts
Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) have been given a consensus rating of 'Moderate Buy' by the ten research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated…
Tour of Slovenia: Florian Lipowitz claims overall title with stage 5 solo victory
Florian Lipowitz (Red Bull-Bora-Hansgrohe) claimed the final stage 5 victory with a late-race attack over the steep slopes of the Trška Gora that saw him solo into Nove Mesto with the day's glory and the overall title at the Tour of Slovenia.
Own 500 Shares of Pfizer and JNJ and Here's Your Annual Dividend Income
Passive income is the closest thing investors have to financial gravity. It pulls in money whether you are at your desk, on a beach, or asleep, and it lands in your account no matter what the broader market did that week. Earned income depends on…
Why FMCG giants buy D2C brands
India's consumer sector is witnessing a significant wave of consolidations. The recent acquisition of Innovist by L'Oreal was but the latest in a long line of such deals. Over the last few years, several large FMCG companies have acquired…
![koreaherald.com - Jo He-rim - [Uzbekistan Forum] Eximbank Korea eyes bigger role as Uzbekistan seeks Korean capital](https://wimg.heraldcorp.com/svc/user/e4c67be4-e066-4cd7-bd95-c202480cc930.jpeg)
[Uzbekistan Forum] Eximbank Korea eyes bigger role as Uzbekistan seeks Korean capital
TASHKENT, Uzbekistan — South Korea's state export lender said it was ready to finance a new wave of Korea-Uzbekistan projects, as Tashkent seeks to draw more Korean capital into infrastructure, supply chains and technology-driven industries…
Receive a Daily briefing on Pharma Industry News
Get Started